Earnings History Data for Burning Rock Biotech Limited (BNR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Burning Rock Biotech Limited
Burning Rock Biotech Limited focuses on the application of next generation sequencing technology in the field of precision oncology. Its business consists of NGS-based therapy selection testing for late-stage cancer patients as well as NGS-based cancer early detection. Burning Rock Biotech Limited is based in GUANGZHOU, China.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29-05-2024 | PM | BNR | Burning Rock Biotech Limited | 77.45 | -0.16 | 0.00 | -2.60 | Burning Rock Biotech GAAP EPS of -$0.16, revenue of $17.4M [5/29/2024 1:47 AM] |
7.55 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
5.72 - 29.00 | 2,310 | 10,000 | 0 | ||
| 30-11-2023 | PM | BNR | Burning Rock Biotech Limited | 89.81 | -0.23 | 0.00 | -0.31 | Burning Rock Biotech GAAP EPS of -$0.23, revenue of $17.5M [11/30/2023 2:30 AM] |
0.83 | -0.07 (-7.31%) |
0.87 | -0.03 (-2.95%) |
0.83 - 3.80 | 83,253 | 60,000 | 750 | ||
| 31-08-2023 | PM | BNR | Burning Rock Biotech Limited | 139.60 | -0.18 | 0.00 | -0.37 | Burning Rock Biotech GAAP EPS of -$0.18, revenue of $20.2M [8/31/2023 2:15 AM] |
1.31 | -0.05 (-3.68%) |
0.0 | 0.0 (0.00%) |
1.23 - 4.24 | 43,484 | 30,000 | 0 | ||
| 30-05-2023 | PM | Before the open (May 30) |
BNR | Burning Rock Biotech Limited | 272.09 | -0.26 | -0.20 | -0.39 | Burning Rock Biotech GAAP EPS of -$0.26, revenue of $20.8M; reaffirms FY23 guidance [5/30/2023 1:13 AM] |
2.71 | 0.05 (1.88%) |
2.50 | -0.16 (-6.02%) |
1.70 - 4.24 | 44,204 | 40,000 | 1,103 | |
| 28-03-2023 | PM | Before the open (Mar 28) |
BNR | Burning Rock Biotech Limited | 304.49 | -0.31 | 0.00 | -0.38 | Burning Rock Biotech GAAP EPS of -$0.31, revenue of $20.6M [3/28/2023 3:35 AM] |
2.94 | 0.09 (3.15%) |
0.0 | 0.0 (0.00%) |
1.70 - 11.27 | 59,456 | 80,000 | 0 | |
| 15-11-2022 | PM | 5:30 AM ET (Nov 16) |
BNR | Burning Rock Biotech Limited | 237.88 | -0.31 | -0.28 | -0.25 | Burning Rock Biotech GAAP EPS of -$0.31 beats by $0.03, revenue of $21.74M misses by $0.32M [11/16/2022 2:20 AM] |
2.24 | -0.04 (-1.75%) |
2.51 | 0.23 (10.07%) |
1.70 - 17.66 | 177,599 | 290,000 | 13,929 | |
| 31-08-2022 | PM | 2:30 AM ET (Aug 31) |
BNR | Burning Rock Biotech Limited | 331.34 | -0.37 | -0.36 | -0.30 | Burning Rock Biotech GAAP EPS of -$0.37 misses by $0.01, revenue of $19.5M misses by $2.94M [8/31/2022 5:38 AM] |
3.93 | 0.68 (20.92%) |
3.15 | -0.10 (-3.08%) |
1.74 - 21.36 | 1,960,621 | 600,000 | 995 | |
| 31-05-2022 | PM | 0:30 AM ET (May 31) |
BNR | Burning Rock Biotech Limited | 250.35 | -0.39 | -0.23 | -0.25 | Burning Rock Biotech GAAP EPS of -$0.39 misses by $0.01, revenue of $21.4M misses by $0.32M [5/31/2022 3:29 AM] |
2.40 | 0.02 (0.63%) |
2.70 | 0.32 (13.45%) |
2.31 - 30.50 | 862,862 | 490,000 | 17,306 | |
| 21-03-2022 | PM | Before the open (Mar 22) |
BNR | Burning Rock Biotech Limited | 964.98 | -0.38 | 0.00 | -0.23 | Burning Rock Biotech GAAP EPS of -$0.38, revenue of $23.12M [3/22/2022 12:21 AM] |
9.30 | 0.46 (5.20%) |
8.84 | 0.0 (0.00%) |
6.65 - 38.64 | 241,894 | 276,621 | 133 | |
| 15-11-2021 | PM | 0:30 AM ET (Nov 16) |
BNR | Burning Rock Biotech Limited | 1,530 | -0.25 | -0.19 | -0.18 | Burning Rock Biotech misses on revenue [11/16/2021 4:51 AM] |
15.19 | 1.44 (10.44%) |
13.50 | -0.25 (-1.82%) |
12.24 - 39.75 | 524,729 | 260,000 | 853 | |
| 31-08-2021 | PM | 0:20 AM ET (Aug 31) |
BNR | Burning Rock Biotech Limited | 2,020 | -0.30 | -0.14 | -0.38 | Burning Rock Biotech misses on revenue; updates full year guidance [8/31/2021 5:25 AM] |
18.55 | -1.38 (-6.92%) |
18.65 | -1.28 (-6.42%) |
17.56 - 39.75 | 484,504 | 270,000 | 4,246 | |
|
||||||||||||||||||
| 25-05-2021 | PM | 6:00 AM ET (May 25) |
BNR | Burning Rock Biotech Limited | 3,850 | -0.25 | -0.14 | 0.00 | Burning Rock Biotech misses on revenue, reiterates FY 2021 revenue guidance [5/25/2021 4:03 AM] |
33.23 | -0.42 (-1.25%) |
31.50 | -2.15 (-6.39%) |
18.64 - 39.75 | 1,087,174 | 480,000 | 2,749 | |
| 10-03-2021 | PM | 6:00 AM ET (Mar 11) |
BNR | Burning Rock Biotech Limited | 3,550 | -0.23 | -0.16 | 0.00 | Burning Rock Biotech EPS misses by $0.04, beats on revenue [3/11/2021 1:43 AM] |
30.22 | -2.02 (-6.27%) |
35.01 | 2.77 (8.59%) |
18.64 - 39.75 | 368,870 | 503,273 | 817 | |
| 20-11-2020 | PM | 0:40 AM ET (Nov 20) |
BNR | Burning Rock Biotech Limited | 2,730 | -0.18 | -0.11 | 0.00 | Burning Rock Biotech EPS misses by $0.08, beats on revenue [11/20/2020 6:02 AM] |
24.16 | -1.77 (-6.83%) |
0.0 | 0.0 (0.00%) |
18.64 - 32.40 | 551,671 | 103,304 | 0 | |
| 11-08-2020 | PM | Before the open (Aug 11) |
BNR | Burning Rock Biotech Limited | 2,350 | -0.38 | -0.20 | 0.00 | Burning Rock Biotech EPS misses by $0.30, beats on revenue [8/11/2020 2:05 AM] |
22.01 | -1.78 (-7.48%) |
24.49 | 0.70 (2.94%) |
21.60 - 32.40 | 141,024 | 71,994 | 319 | |
|
|
||||||||||||||||||